162 related articles for article (PubMed ID: 37642716)
1. Characterization of an efficient CRISPR-iCas9 system in Yarrowia lipolytica for the biosynthesis of carotenoids.
Chen QH; Qian YD; Niu YJ; Hu CY; Meng YH
Appl Microbiol Biotechnol; 2023 Oct; 107(20):6299-6313. PubMed ID: 37642716
[TBL] [Abstract][Full Text] [Related]
2. A CRISPR/Cas9-Mediated, Homology-Independent Tool Developed for Targeted Genome Integration in Yarrowia lipolytica.
Cui Z; Zheng H; Zhang J; Jiang Z; Zhu Z; Liu X; Qi Q; Hou J
Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33452022
[No Abstract] [Full Text] [Related]
3. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
4. Metabolic engineering of β-carotene biosynthesis in Yarrowia lipolytica.
Zhang XK; Wang DN; Chen J; Liu ZJ; Wei LJ; Hua Q
Biotechnol Lett; 2020 Jun; 42(6):945-956. PubMed ID: 32090297
[TBL] [Abstract][Full Text] [Related]
5. Improving CRISPR/Cas9-mediated genome editing efficiency in Yarrowia lipolytica using direct tRNA-sgRNA fusions.
Abdel-Mawgoud AM; Stephanopoulos G
Metab Eng; 2020 Nov; 62():106-115. PubMed ID: 32758536
[TBL] [Abstract][Full Text] [Related]
6. Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system.
Gao S; Tong Y; Wen Z; Zhu L; Ge M; Chen D; Jiang Y; Yang S
J Ind Microbiol Biotechnol; 2016 Aug; 43(8):1085-93. PubMed ID: 27349768
[TBL] [Abstract][Full Text] [Related]
7. Standardized Markerless Gene Integration for Pathway Engineering in Yarrowia lipolytica.
Schwartz C; Shabbir-Hussain M; Frogue K; Blenner M; Wheeldon I
ACS Synth Biol; 2017 Mar; 6(3):402-409. PubMed ID: 27989123
[TBL] [Abstract][Full Text] [Related]
8. Synthetic RNA Polymerase III Promoters Facilitate High-Efficiency CRISPR-Cas9-Mediated Genome Editing in Yarrowia lipolytica.
Schwartz CM; Hussain MS; Blenner M; Wheeldon I
ACS Synth Biol; 2016 Apr; 5(4):356-9. PubMed ID: 26714206
[TBL] [Abstract][Full Text] [Related]
9. CRISPR Interference and Activation to Modulate Transcription in Yarrowia lipolytica.
Misa J; Schwartz C
Methods Mol Biol; 2021; 2307():95-109. PubMed ID: 33847984
[TBL] [Abstract][Full Text] [Related]
10. Expansion of YALIcloneHR toolkit for Yarrowia lipolytica combined with Golden Gate and CRISPR technology.
Shen Q; Yan F; Li YW; Wang J; Ji J; Yan WX; He DC; Song P; Shi TQ
Biotechnol Lett; 2024 Feb; 46(1):37-46. PubMed ID: 38064043
[TBL] [Abstract][Full Text] [Related]
11. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
Yang Z; Xu P
Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
[TBL] [Abstract][Full Text] [Related]
12. Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system.
Shi TQ; Huang H; Kerkhoven EJ; Ji XJ
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9541-9548. PubMed ID: 30238143
[TBL] [Abstract][Full Text] [Related]
13. Multiple Parameters Drive the Efficiency of CRISPR/Cas9-Induced Gene Modifications in Yarrowia lipolytica.
Borsenberger V; Onésime D; Lestrade D; Rigouin C; Neuvéglise C; Daboussi F; Bordes F
J Mol Biol; 2018 Oct; 430(21):4293-4306. PubMed ID: 30227135
[TBL] [Abstract][Full Text] [Related]
14. Multiplex Gene Disruption by Targeted Base Editing of Yarrowia lipolytica Genome Using Cytidine Deaminase Combined with the CRISPR/Cas9 System.
Bae SJ; Park BG; Kim BG; Hahn JS
Biotechnol J; 2020 Jan; 15(1):e1900238. PubMed ID: 31657874
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Engineering of
Zhang G; Chen J; Wang Y; Liu Z; Mao X
J Agric Food Chem; 2023 Sep; 71(37):13828-13837. PubMed ID: 37676277
[TBL] [Abstract][Full Text] [Related]
16. EasyCloneYALI: CRISPR/Cas9-Based Synthetic Toolbox for Engineering of the Yeast Yarrowia lipolytica.
Holkenbrink C; Dam MI; Kildegaard KR; Beder J; Dahlin J; Doménech Belda D; Borodina I
Biotechnol J; 2018 Sep; 13(9):e1700543. PubMed ID: 29377615
[TBL] [Abstract][Full Text] [Related]
17. Dual CRISPR-Cas9 Cleavage Mediated Gene Excision and Targeted Integration in Yarrowia lipolytica.
Gao D; Smith S; Spagnuolo M; Rodriguez G; Blenner M
Biotechnol J; 2018 Sep; 13(9):e1700590. PubMed ID: 29809313
[TBL] [Abstract][Full Text] [Related]
18. A set of Yarrowia lipolytica CRISPR/Cas9 vectors for exploiting wild-type strain diversity.
Larroude M; Trabelsi H; Nicaud JM; Rossignol T
Biotechnol Lett; 2020 May; 42(5):773-785. PubMed ID: 31974649
[TBL] [Abstract][Full Text] [Related]
19. Gene repression via multiplex gRNA strategy in Y. lipolytica.
Zhang JL; Peng YZ; Liu D; Liu H; Cao YX; Li BZ; Li C; Yuan YJ
Microb Cell Fact; 2018 Apr; 17(1):62. PubMed ID: 29678175
[TBL] [Abstract][Full Text] [Related]
20. Construction of wild-type Yarrowia lipolytica IMUFRJ 50682 auxotrophic mutants using dual CRISPR/Cas9 strategy for novel biotechnological approaches.
de Souza CP; Ribeiro BD; Zarur Coelho MA; Almeida RV; Nicaud JM
Enzyme Microb Technol; 2020 Oct; 140():109621. PubMed ID: 32912681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]